ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT-Reference-Cited by-同舟云学术

ABO incompatibility in mismatched unrelated donor allogeneic hematopoietic cell transplantation for acute myeloid leukemia: A report from the acute leukemia working party of the EBMT

Published:2017-06-09 Issue:8 Volume:92 Page:789-796
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Canaani Jonathan¹^ORCID,Savani Bipin N.²,Labopin Myriam³⁴⁵,Michallet Mauricette⁶,Craddock Charles⁷,Socié Gerard³,Volin Lisa⁸,Maertens Johan A.⁹,Crawley Charles¹⁰,Blaise Didier¹¹,Ljungman Per T.¹²,Cornelissen Jan¹³,Russell Nigel¹⁴,Baron Frédéric¹⁵,Gorin Norbert⁴⁵,Esteve Jordi¹⁶,Ciceri Fabio¹⁷,Schmid Christoph¹⁸,Giebel Sebastian¹⁹,Mohty Mohamad⁴⁵,Nagler Arnon¹³

Affiliation:

1. Hematology Division, Chaim Sheba Medical Center, Tel-Hashomer, Tel Aviv University; Israel

2. Vanderbilt University Medical Center; Nashville Tennessee

3. Acute Leukemia Working Party-EBMT and Department of Hematology and Cell Therapy; Hȏpital Saint-Antoine; Paris

4. INSERM UMR 938; Paris France

5. Université Pierre et Marie Curie; Paris France

6. Centre Hospitalier Lyon Sud; Hematological Unit, Hospices Civils de Lyon; France

7. Centre for Clinical Haematology, Queen Elizabeth Hospital; Birmingham United Kingdom

8. HUH, Comprehensive Cancer Center, Stem Cell Transplantation Unit; Helsinki Finland

9. University Hospitals Leuven, Campus Gasthuisberg; Leuven Belgium

10. Addenbrooke's Hospital, Cambridge; England United Kingdom

11. Programme de Transplantation & Therapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes; Marseille France

12. Department of Hematology; Karolinska University Hospital; Stockholm Sweden

13. Department of Hematology; Erasmus MC Cancer Institute, University Medical Center Rotterdam; The Netherlands

14. Department of Haematology; City Hospital, Nottingham University NHS Trust; Nottingham United Kingdom

15. Department of Medicine, Division of Hematology; CHU of Liège; Liège Belgium

16. Department of Hematology; Hospital Clinic; Barcelona Spain

17. Department of Hematology; Ospedale San Raffaele, Università degli Studi; Milano Italy

18. Klinikum Augsburg, Department of Hematology and Oncology; University of Munich; Augsburg Germany

19. Maria Sklodowska-Curie Cancer Center and Institute of Oncology; Gliwice Branch Poland

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.24771/fullpdf

Reference35 articles.

1. Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist;Kekre;Blood.,2014

2. Outcomes of patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation from matched unrelated donors compared with one human leukocyte antigen mismatched related donors using HLA typing at 10 loci;Ciurea;Biol Blood Marrow Transplant.,2011

3. HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry;Crocchiolo;Bone Marrow Transplant.,2009

4. Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT;Savani;Haematologica.,2016

5. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation;Lee;Blood.,2007

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immuno-Hematologic Complexity of ABO-Incompatible Allogeneic HSC Transplantation;Cells;2024-05-10

2. SOHO State of the Art Updates and Next Questions | Current Status and Future Directions of Donor Selection;Clinical Lymphoma Myeloma and Leukemia;2024-05

3. The impact of infused red blood cell volume on major and bidirectional ABO-mismatched bone marrow transplantation;Cytotherapy;2024-05

4. Immuno-hematological monitoring after allogeneic stem cell transplantation: a single-center, prospective study of 104 patients;BLOOD TRANSFUS-ITALY;2022

5. Impact of Donor-to-Recipient ABO Mismatch on Outcomes of Antithymocyte Globulin-Based Peripheral Blood Stem Cell-Derived Myeloablative Conditioning Haploidentical Stem Cell Transplantation;Transplantation and Cellular Therapy;2022-06